Scoring Atopic Dermatitis (SCORAD) Index: A Full Guide for Researchers and Clinicians.

Published 2025-05-13

The Scoring Atopic Dermatitis Index is a tool to assess the severity of atopic dermatitis. Explore its components, scoring, and applications.

Introduction

Atopic Dermatitis (AD), commonly known as eczema, is a chronic inflammatory skin disorder affecting both children and adults. Reliable assessment tools are critical to monitor disease severity, plan treatment, and evaluate outcomes in clinical practice and research. The Severity Scoring of Atopic Dermatitis (SCORAD) index, developed by the European Task Force on Atopic Dermatitis (ETFAD) in 1993, is one of the most widely used clinician-administered tools for assessing AD.

This article offers a comprehensive overview of the SCORAD index, its purpose, scoring method, validation, and practical applications. Whether you're a researcher or clinician, understanding SCORAD can help ensure accurate, evidence-based evaluation of eczema severity.

Key Features of the Scoring Atopic Dermatitis Index

Purpose and Use

The SCORAD index is designed to assess the severity of atopic dermatitis through three components:

Extent of skin involvement (body surface area).

Intensity of six clinical signs (e.g., erythema, edema).

Subjective symptoms such as itch and sleep disturbance.

This multifaceted approach allows clinicians to evaluate both objective and patient-reported symptoms, making SCORAD essential for diagnosis, monitoring, and research.

Target Population

The Scoring Atopic Dermatitis is validated for use across all age groups, including:

Children (under 13 years)

Adolescents

Young and middle-aged adults

Older adults and seniors

Its broad applicability enhances its usefulness in pediatric and adult dermatology.

Domains and Sub-domains

Main Domain:

Dermatology / Skin Health

Sub-domains:

Extent – Body surface area affected

Intensity – Clinical signs (e.g., oozing, lichenification)

Subjective Symptoms – Itch and sleep disturbance

Structure

SCORAD consists of:

1 item for extent

6 items for intensity (scored 0–3 each)

2 items for subjective symptoms (scored 0–10 each)

Scoring Method

The SCORAD score is calculated using the following formula:

A/5 + 7B/2 + C

Where:

A = Extent (% of body surface area, calculated via the “rule of 9s”)

B = Intensity score (0–18)

C = Subjective symptoms (0–20)

Score Interpretation:

Mild AD: <25

Moderate AD: 25–50

Severe AD: >50

This formula provides a maximum score of 103, reflecting overall disease severity.

Administration Format

The SCORAD index can be administered in the following formats:

Paper-based (clinician-administered)

Digital forms (online or electronic)

In-person interviews

Due to its clinical nature, SCORAD typically requires healthcare professionals for accurate administration.

Applications of the Scoring Atopic Dermatitis Index

SCORAD is used for:

Screening: Identifying AD severity

Diagnosis: Determining the clinical state

Monitoring: Evaluating treatment effectiveness over time

Research: Standardizing data collection in dermatology studies

Languages Available

SCORAD is available in more than 40 languages, including:

English

French

Spanish

German

Mandarin Chinese

Russian

Japanese

Portuguese

Reliability and Validity

SCORAD has been highly validated, with more than 5,000 academic citations. It shows strong:

Construct validity

Sensitivity to change

Inter-rater reliability

Limitations and Considerations

Despite its many strengths, SCORAD does have limitations:

Not a self-report tool: Requires trained clinicians

Cultural bias: May affect interpretation of subjective symptoms

Scoring complexity: Involves multiple steps and components

Subjectivity: Patient-reported symptoms may vary

Nevertheless, SCORAD remains a reliable and widely used index in dermatology

Additional Resources

For more information on the SCORAD and to access the full questionnaire, visit the following resources:

A direct link to the Original Validation Study

You can access the questionnaire as a PDF through this link

For inquiries, contact authors through this link

Frequently Asked Questions (FAQ)

Is SCORAD suitable for self-reporting?

No. SCORAD is clinician-administered and requires basic training for accurate use.

How long does it take to complete the SCORAD?

Approximately 10–15 minutes, depending on clinical setup and patient cooperation.

What are common alternatives to SCORAD?

EASI (Eczema Area and Severity Index) and POEM (Patient-Oriented Eczema Measure) are commonly used complementary tools.

Is SCORAD validated for children?

Yes, SCORAD is suitable for all age groups, including pediatric patients over 18 months.

A word from ResRef

The SCORAD index is a clinician-administered tool assessing atopic dermatitis severity through three components: extent (body surface area), intensity (six clinical signs), and subjective symptoms (itch/sleep loss). While widely used and validated, it requires specialized expertise for scoring and has limitations including cultural bias, complexity, and scoring subjectivity. It is free, available in over 40 languages, and suitable for all age groups except infants under 18 months.

References

Stalder, J.F., Taïeb, A., et al. (1993). Severity scoring of atopic dermatitis: the SCORAD index. Dermatology, 186(1), 23–31. https://doi.org/10.1159/000247298. Link